Company intelligence / Profile preview

The Sterlington Group

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

The Sterlington Group is a boutique investment bank based in New York City focused on healthcare and life sciences clients. The firm provides capital raising, mergers and acquisitions advisory, and CFO consulting services rather than developing therapeutics or operating a drug pipeline. Its public materials emphasize strategic and financing support for healthcare and life sciences companies, with leadership led by Jack Weinstein, who has prior operating and finance experience in specialty pharmaceuticals. Based on the available evidence, The Sterlington Group is a healthcare-focused services firm, not a biotech, pharma, CRO, or therapeutic product company.

Industry: Investors

Beyond the preview

Go deeper on The Sterlington Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Sterlington Group.

Explore the full profile